Credit Suisse’s Orthofix Medical OFIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $603K | Sell |
41,519
-321
| -0.8% | -$4.44K | ﹤0.01% | 2549 |
|
|
2023
Q4 | $564K | Sell |
41,840
-699
| -2% | -$8.21K | ﹤0.01% | 2674 |
|
|
2023
Q3 | $547K | Sell |
42,539
-1,123
| -3% | -$20.2K | ﹤0.01% | 2632 |
|
|
2023
Q2 | $789K | Buy |
43,662
+2,434
| +6% | +$45.5K | ﹤0.01% | 2543 |
|
|
2023
Q1 | $691K | Buy |
41,228
+21,537
| +109% | +$421K | ﹤0.01% | 2545 |
|
|
2022
Q4 | $404K | Buy |
19,691
+5,296
| +37% | +$93.4K | ﹤0.01% | 2905 |
|
|
2022
Q3 | $275K | Buy |
14,395
+114
| +0.8% | +$2.56K | ﹤0.01% | 3118 |
|
|
2022
Q2 | $336K | Sell |
14,281
-2,260
| -14% | -$64.7K | ﹤0.01% | 3098 |
|
|
2022
Q1 | $540K | Buy |
16,541
+2,088
| +14% | +$67.1K | ﹤0.01% | 2930 |
|
|
2021
Q4 | $450K | Buy |
14,453
+828
| +6% | +$27.7K | ﹤0.01% | 3891 |
|
|
2021
Q3 | $520K | Sell |
13,625
-2,157
| -14% | -$85.9K | ﹤0.01% | 3774 |
|
|
2021
Q2 | $634K | Sell |
15,782
-168
| -1% | -$7.1K | ﹤0.01% | 3686 |
|
|
2021
Q1 | $691K | Sell |
15,950
-3,305
| -17% | -$146K | ﹤0.01% | 3555 |
|
|
2020
Q4 | $828K | Buy |
19,255
+5,610
| +41% | +$205K | ﹤0.01% | 3464 |
|
|
2020
Q3 | $425K | Buy |
13,645
+1,942
| +17% | +$60.2K | ﹤0.01% | 3472 |
|
|
2020
Q2 | $375K | Sell |
11,703
-2,683
| -19% | -$89K | ﹤0.01% | 3472 |
|
|
2020
Q1 | $403K | Sell |
14,386
-3,178
| -18% | -$123K | ﹤0.01% | 3239 |
|
|
2019
Q4 | $811K | Buy |
17,564
+1,711
| +11% | +$80.4K | ﹤0.01% | 3272 |
|
|
2019
Q3 | $840K | Buy |
15,853
+4,219
| +36% | +$218K | ﹤0.01% | 3127 |
|
|
2019
Q2 | $616K | Sell |
11,634
-6,132
| -35% | -$326K | ﹤0.01% | 3281 |
|
|
2019
Q1 | $1M | Buy |
17,766
+411
| +2% | +$23.1K | ﹤0.01% | 2888 |
|
|
2018
Q4 | $910K | Buy |
17,355
+5,293
| +44% | +$301K | ﹤0.01% | 2857 |
|
|
2018
Q3 | $698K | Sell |
12,062
-7,739
| -39% | -$434K | ﹤0.01% | 3101 |
|
|
2018
Q2 | $1.13M | Sell |
19,801
-4,210
| -18% | -$240K | ﹤0.01% | 2930 |
|
|
2018
Q1 | $1.41M | Buy |
24,011
+8,900
| +59% | +$499K | ﹤0.01% | 2705 |
|
|
2017
Q4 | $826K | Sell |
15,111
-8,642
| -36% | -$448K | ﹤0.01% | 3130 |
|
|
2017
Q3 | $1.12M | Buy |
23,753
+14,476
| +156% | +$682K | ﹤0.01% | 3010 |
|
|
2017
Q2 | $431K | Sell |
9,277
-7,342
| -44% | -$305K | ﹤0.01% | 3247 |
|
|
2017
Q1 | $635K | Sell |
16,619
-30,557
| -65% | -$1.13M | ﹤0.01% | 3145 |
|
|
2016
Q4 | $1.71M | Buy |
47,176
+25,749
| +120% | +$977K | ﹤0.01% | 2562 |
|
|
2016
Q3 | $917K | Sell |
21,427
-12,020
| -36% | -$536K | ﹤0.01% | 3030 |
|
|
2016
Q2 | $1.42M | Sell |
33,447
-20,715
| -38% | -$901K | ﹤0.01% | 2622 |
|
|
2016
Q1 | $2.25M | Buy |
54,162
+27,500
| +103% | +$1.08M | ﹤0.01% | 2112 |
|
|
2015
Q4 | $1.05M | Buy |
26,662
+11,570
| +77% | +$432K | ﹤0.01% | 2780 |
|
|
2015
Q3 | $509K | Sell |
15,092
-16,606
| -52% | -$591K | ﹤0.01% | 3368 |
|
|
2015
Q2 | $1.05M | Buy |
31,698
+18,126
| +134% | +$623K | ﹤0.01% | 3133 |
|
|
2015
Q1 | $487K | Sell |
13,572
-11,987
| -47% | -$377K | ﹤0.01% | 3551 |
|
|
2014
Q4 | $769K | Buy |
25,559
+2,090
| +9% | +$61.3K | ﹤0.01% | 3368 |
|
|
2014
Q3 | $726K | Sell |
23,469
-3,362
| -13% | -$112K | ﹤0.01% | 3338 |
|
|
2014
Q2 | $972K | Sell |
26,831
-25,771
| -49% | -$833K | ﹤0.01% | 3306 |
|
|
2014
Q1 | $1.59M | Sell |
52,602
-78,325
| -60% | -$1.81M | ﹤0.01% | 2707 |
|
|
2013
Q4 | $2.99M | Buy |
130,927
+29,944
| +30% | +$626K | ﹤0.01% | 2304 |
|
|
2013
Q3 | $2.1M | Buy |
100,983
+12,174
| +14% | +$296K | ﹤0.01% | 2355 |
|
|
2013
Q2 | $2.39M | Buy |
+88,809
| New | +$2.66M | ﹤0.01% | 2136 |
|
Other funds holding OFIX
AC
RCMNY
ECM
PCMI
NM
BCM
Credit Suisse's OFIX Position: Q1 2024 in Review
Credit Suisse reduced its Orthofix Medical (OFIX) stake by 0.77% in Q1 2024, selling an estimated $4.44K and leaving 41,519 shares worth $603K. The position accounts for ﹤0.01% of the portfolio, ranked #2549.
Credit Suisse first reported a position in OFIX in Q2 2013 and has held it in 44 quarters since. The position peaked at $2.99M in Q4 2013. 136 funds tracked by Wall St. Rank hold OFIX as of Q1 2024.
- Credit Suisse held 41,519 shares of Orthofix Medical worth $603K as of Q1 2024.
- Credit Suisse sold 321 Orthofix Medical shares in Q1 2024, an estimated $4.44K.
- Orthofix Medical made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2549 holding.
- Credit Suisse first reported a position in Orthofix Medical in Q2 2013 and has held it in 44 quarters since.
- Credit Suisse's Orthofix Medical position peaked at $2.99M in Q4 2013.
- 136 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.